Advanced Proteome Therapeutics Corporation reported earnings results for the second quarter and six months ended January 31, 2022. For the second quarter, the company reported net income was USD 0.627774 million compared to USD 0.027541 million a year ago. Basic earnings per share from continuing operations was USD 0.02.
For the six months, net income was USD 1.3 million compared to net loss of USD 0.314695 million a year ago. Basic earnings per share from continuing operations was USD 0.04 compared to basic loss per share from continuing operations of USD 0.01 a year ago.